Simplify Propel Opportunities ETF Rating $17.53 0.00 (0.00%) As of 06/12/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.57Holdings in SURI have an aggregate rating of Moderate Buy based on 188 analyst ratings issued in the past year covering 23 companies (94.4% of the portfolio).SURI Aggregate Price Target$17.53High Prediction$17.53Average Prediction$17.53Low Prediction$17.53Holdings in SURI have an aggregate price target of $17.53 and a range of $17.53 to $17.53 covering 23 companies (94.4% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 SURI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings42.31%PAGPPlains GP$24.08-1.2%1.8558 of 5 stars2.36$23.00 -4.5%14News CoverageDividend Announcement10.16%ACHVAchieve Life Sciences$5.66+2.5%2.6862 of 5 stars3.00$14.67 159.1%6Positive News5.80%MISTMilestone Pharmaceuticals$1.31+2.8%2.5287 of 5 stars2.50$7.25 455.6%6Positive News3.91%ABEOAbeona Therapeutics$5.57+0.7%2.8698 of 5 stars2.33$19.00 241.1%33.79%CORTCorcept Therapeutics$80.40-3.0%3.8467 of 5 stars2.75$88.83 10.5%8Positive News3.78%DCTHDelcath Systems$11.95+1.9%2.7568 of 5 stars2.43$22.50 88.4%7Gap Up3.30%PHATPhathom Pharmaceuticals$10.47+1.0%2.4953 of 5 stars2.86$24.50 134.0%72.37%CLDXCelldex Therapeutics$31.80+1.7%2.1736 of 5 stars2.82$49.30 55.1%11News CoverageGap Down2.00%CMPSCompass Pathways$12.16+0.6%3.5047 of 5 stars2.93$21.36 75.7%14Positive NewsGap Down1.95%KYTXKyverna Therapeutics$8.21+1.9%2.8344 of 5 stars2.67$30.00 265.4%6Positive News1.72%LONAAthira Pharma$8.88+6.3%3.9144 of 5 stars2.40$15.00 68.9%5Positive News1.68%IVAInventiva$3.80-1.3%2.7769 of 5 stars3.10$16.56 335.7%101.67%PALIPalisade Bio$1.72+0.3%1.8809 of 5 stars2.88$10.20 494.8%8Gap Up1.55%AQSTAquestive Therapeutics$4.21+0.8%2.5084 of 5 stars3.00$8.80 109.3%8Positive News1.44%ZVRAZevra Therapeutics$12.68+0.2%4.3138 of 5 stars2.80$29.29 131.0%10Gap Up1.17%OBIOOrchestra BioMed$4.10-0.1%4.325 of 5 stars2.57$13.60 232.1%7Positive NewsHigh Trading Volume1.04%ARTVArtiva Biotherapeutics$9.24+8.1%3.869 of 5 stars2.83$39.00 322.3%6News CoverageShort Interest Increase0.96%OCULOcular Therapeutix$8.95+0.1%2.9335 of 5 stars2.79$23.78 165.7%14Gap Down0.87%SABSSAB Biotherapeutics$4.05+21.7%4.004 of 5 stars2.70$11.63 187.0%10Positive NewsGap Up0.85%IMUXImmunic$13.84-0.1%3.0119 of 5 stars3.00$47.57 243.7%11Gap Down0.75%EYPTEyepoint Pharmaceuticals$13.15+0.9%2.7625 of 5 stars3.00$31.80 141.9%7Positive News0.71%CASHPathward Financial$85.04+1.0%4.3993 of 5 stars3.00$107.50 26.4%30.62%UPBUpstream Bio$6.11+0.2%2.7343 of 5 stars2.43$33.17 442.8%7News CoverageAnalyst Downgrade This page (NYSEARCA:SURI) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SURI Stock Alerts